× Posted: April 09 2019 FDA's Center for Drug Evaluation and Research Releases Statement on New Opioid Analgesic Labeling Changes Douglas Throckmorton, M.D., releases statement on behalf of FDA addressing changes to new opioid analgesic labeling. Read more.
Posted: April 09 2019 FDA's Center for Drug Evaluation and Research Releases Statement on New Opioid Analgesic Labeling Changes Douglas Throckmorton, M.D., releases statement on behalf of FDA addressing changes to new opioid analgesic labeling. Read more.